Atlas Trials

Clinical Study of AAV1-gamma-sarcoglycan Gene Therapy for Limb Girdle Muscular Dystrophy Type 2C

Clinical trial NCT01344798 · COMPLETED

Trial details

NCT number
NCT01344798
Sponsor
Genethon
Status
COMPLETED
Phase
Phase 1
Study type
INTERVENTIONAL
Limb Girdle Muscular Dystrophy Type 2CGamma-sarcoglycanopathy
Start date
2006-11-01
Primary completion
2010-06-01
Enrollment
9

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.